FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Ustekinumab (Stelara) by Janssen Biotech, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

SUPPL AP for USTEKINUMAB (USTEKINUMAB)